Core Viewpoint - The article highlights the performance of the Shanghai Composite Index and the Hang Seng Index, along with the premium of China Communications Construction Company (CCCC) in the A/H share market, emphasizing its leading position in the global infrastructure sector [1]. Group 1: Market Performance - On August 13, the Shanghai Composite Index rose by 0.48%, closing at 3683.46 points, while the Hang Seng Index increased by 2.58%, closing at 25613.67 points [1]. Group 2: Company Overview - China Communications Construction Company (CCCC) is a global leader in large-scale infrastructure services, primarily engaged in the investment, construction, and operation of transportation infrastructure, equipment manufacturing, and urban development [1]. - CCCC provides a comprehensive range of solutions including investment financing, consulting planning, design and construction, and management operations [1]. Group 3: Competitive Position - CCCC is recognized as the world's largest port design and construction company, the largest road and bridge design and construction company, the largest dredging company, and the largest manufacturer of container cranes [1]. - The company is also a leading provider of offshore drilling platform design and equipment, and it holds the title of Asia's largest international engineering contractor and China's largest highway investor [1]. Group 4: A/H Share Premium - The A/H premium for CCCC reached 74.55%, ranking it 44th among A/H shares, indicating that H shares are relatively cheaper compared to A shares [1]. - As of the close, CCCC's A shares were priced at 9.27 yuan, with a decline of 0.32%, while H shares were priced at 5.81 HKD, with an increase of 0.17% [1].

Core Viewpoint - The article highlights the performance of the Shanghai Composite Index and the Hang Seng Index, along with the premium of China Galaxy Securities' A-shares over H-shares, indicating a favorable market position for the company [1][2]. Company Overview - China Galaxy Securities Co., Ltd. is a leading comprehensive financial service provider in China's securities industry, recognized for its historical significance, brand strength, and shareholder advantages [1]. - The company ranks among the top in the industry in terms of capital scale, profitability, business strength, and risk management capabilities [1]. Financial Performance - As of the latest trading day, China Galaxy's A-shares closed at 17.74 yuan, with an increase of 1.49%, while its H-shares closed at 11.34 Hong Kong dollars, up by 1.25% [1]. - The A/H premium for China Galaxy reached 71.14%, placing it at the 48th position in terms of A/H stock premium rates [1].

Group 1 - The Shanghai Composite Index rose by 0.48% to close at 3683.46 points, while the Hang Seng Index increased by 2.58% to 25613.67 points [1] - China Shipbuilding Defense's A-H share premium reached 93.32%, ranking 33rd among A-H shares [1] - At the close, China Shipbuilding Defense's A-shares were priced at 29.37 yuan, with a gain of 0.17%, and H-shares were priced at 16.62 HKD, up by 2.09% [1] Group 2 - China Shipbuilding Defense Equipment Co., Ltd. is a major shipbuilding enterprise under China Shipbuilding Group, originally established as Guangzhou Shipyard International Co., Ltd. [1] - The company was listed in Shanghai and Hong Kong in 1993, becoming the first A+H share listed shipbuilding company in China [1] - To promote industry consolidation and enhance competitiveness, China Shipbuilding Defense acquired several companies in 2014 and 2015, integrating quality shipbuilding assets in South China [1] - The company aims to become a leading enterprise in the global marine and heavy equipment market, focusing on technology and service excellence [1]

Group 1 - The core point of the article highlights the performance of the Shanghai Composite Index and the Hang Seng Index, with the former rising by 0.48% to close at 3683.46 points and the latter increasing by 2.58% to close at 25613.67 points [1] - China Railway Signal & Communication Corporation (referred to as China Tonghao) has an AH premium of 71.64%, ranking 47th among AH shares [1] - As of the close, China Tonghao's A-shares were priced at 5.46 yuan, reflecting a 0.55% increase, while its H-shares were priced at 3.48 Hong Kong dollars, showing a decline of 1.14% [1] Group 2 - China Tonghao is a large central enterprise directly supervised by the State-owned Assets Supervision and Administration Commission, specializing in rail transit control technology and is a global leader in rail transit control systems [1] - The company possesses a complete industrial chain that includes investment and financing, design and research, system integration, equipment manufacturing, engineering services, and operation maintenance [1] - China Tonghao has been awarded an A grade in the central enterprise performance assessment for four consecutive years and successfully listed on the Hong Kong Stock Exchange in 2015, becoming the first central enterprise and the first A+H share company to be listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board in 2019 [1]

Group 1 - The Shanghai Composite Index rose by 0.5% to close at 3665.92 points, while the Hang Seng Index increased by 0.25% to 24969.68 points [1] - Hongye Futures has the highest A/H premium at 195.86%, indicating that its H-shares are relatively cheaper compared to A-shares [1] - Hongye Futures A-shares closed at 12.9 yuan with a gain of 1.1%, while its H-shares closed flat at 4.76 Hong Kong dollars [1] Group 2 - Hongye Futures Co., Ltd. was established in 1995 and is a state-owned enterprise fully owned by Jiangsu Provincial State-owned Assets Supervision and Administration Commission [1] - The company operates in various sectors including commodity futures brokerage, financial futures brokerage, futures investment consulting, asset management, and fund sales [1] - Hongye Futures has established 38 branches in major financial centers and key cities across China, ranking among the top in the industry [1] - The company has received multiple honors such as "National Civilized Unit" and "China's Best Futures Company" [1]

Core Viewpoint - The article discusses the performance of the Shanghai Composite Index and the Hang Seng Index, along with the premium of Fudan Zhangjiang's A-shares over H-shares, highlighting the company's position in the biopharmaceutical industry and its ongoing innovations in drug development [1][2]. Group 1: Market Performance - On August 12, the Shanghai Composite Index rose by 0.5%, closing at 3665.92 points, while the Hang Seng Index increased by 0.25%, closing at 24969.68 points [1]. - Fudan Zhangjiang's A-share premium reached 187.84%, ranking third among A/H shares [1]. Group 2: Company Overview - Fudan Zhangjiang Biopharmaceutical Co., Ltd. was established in November 1996 in the Zhangjiang Hi-Tech Park, Shanghai, with notable shareholders including Shanghai Pharmaceuticals Holding Co., Ltd. [1]. - The company focuses on innovative research, development, production, and sales in the biopharmaceutical sector, aiming to become a leading innovation enterprise centered on intellectual property [1]. - Fudan Zhangjiang has developed competitive advantages in various fields, including gene technology drugs, photodynamic therapy drugs, nanotechnology drugs, and oral solid dosage forms, with new drugs expected to be launched in the market [1]. - The company has undertaken several national key technology projects and major scientific initiatives, demonstrating its strength in the biopharmaceutical field [1].

Group 1 - The Shanghai Composite Index rose by 0.5%, closing at 3665.92 points, while the Hang Seng Index increased by 0.25%, closing at 24969.68 points [1] - Sinopec Oilfield Service Corporation (SSC) has an AH premium of 177.02%, ranking fourth among AH shares [1] - SSC's A-shares closed at 2.03 yuan, while its H-shares closed at 0.8 Hong Kong dollars, up by 1.27% [1] Group 2 - SSC is a major integrated oil and gas engineering and technical service company controlled by China Petroleum & Chemical Corporation, with over 60 years of operational experience [1] - The company was formed through the restructuring of various oilfield enterprises and has been listed in both Shanghai and Hong Kong since 2014 [1] - The stock codes for SSC are SH600871 for A-shares and HK1033 for H-shares [1]

Group 1 - The Shanghai Composite Index rose by 0.5% to close at 3665.92 points, while the Hang Seng Index increased by 0.25% to 24969.68 points [1] - Zhongyuan Securities' AH premium reached 77.6%, ranking 41st among AH shares [1] - At the close, Zhongyuan Securities' A-shares were priced at 4.49 yuan, with a gain of 0.45%, and H-shares were priced at 2.76 HKD, up by 1.47% [1] Group 2 - Zhongyuan Securities Co., Ltd. was established on November 8, 2002, and is a key player in the capital market development in Henan [1] - It is one of the 140+ securities firms in China that are listed on both the Hong Kong and domestic main boards, having successfully listed in Hong Kong in June 2014 and on the Shanghai Stock Exchange in January 2017 [1] - Zhongyuan Securities has developed into a comprehensive brokerage firm with a focus on research, investment banking, investment business, wealth management, and asset management, ranking 9th in the industry for the number of companies sponsored for listing and approval rate by the end of 2021 [1]

Group 1 - The Shanghai Composite Index rose by 0.5% to close at 3665.92 points, while the Hang Seng Index increased by 0.25% to 24969.68 points [1] - CanSino Biologics has an AH premium of 91.3%, ranking 35th among AH shares. The A-shares closed at 82.5 yuan, down 3.06%, and the H-shares closed at 47.08 HKD, down 6.96% [1] - CanSino Biologics, founded in 2009 in China, focuses on providing innovative, high-quality, and accessible vaccines for the prevention and treatment of infectious diseases, positioning itself as a leading high-tech biopharmaceutical company [1] Group 2 - The company's mission is to provide innovative, high-quality, and accessible vaccines globally, aiming for the vision of "Innovation without end, a world without epidemics" [1] - CanSino Biologics is listed on both the Hong Kong Stock Exchange (H shares, stock code 6185.HK) and the Shanghai Stock Exchange's STAR Market (A shares, stock code 688185), being the first "A+H" vaccine stock since the launch of the STAR Market [1]

Core Points - The Shanghai Composite Index rose by 0.5% to close at 3665.92 points, while the Hang Seng Index increased by 0.25% to 24969.68 points [1] - Longyuan Power's A/H share premium reached 162.6%, ranking sixth among A/H shares [1] - Longyuan Power's A-shares closed at 16.91 yuan, with a gain of 0.24%, and H-shares closed at 7.03 HKD, up by 0.14% [1] Company Overview - Longyuan Power Group Co., Ltd. was established in 1993 and has undergone several ownership changes, currently under the State Energy Group [1] - The company successfully listed on the Hong Kong main board in 2009 and is recognized as "China's first new energy stock" [1] - In 2022, Longyuan Power became the first H-share new energy power generation central enterprise to return to A-shares, marking several firsts in the domestic capital market [1] - Longyuan Power is a pioneer in wind power development in China, leading in offshore, low wind speed, and high altitude wind power sectors [1] - Since 2015, Longyuan Power has maintained its position as the world's largest wind power operator [1]